≡

ELISA Kit for EGF Like Domain Protein, Multiple 7 (EGFL7)

ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7

Specificity

This assay has high sensitivity and excellent specificity for detection of EGF Like Domain Protein, Multiple 7 (EGFL7).
No significant cross-reactivity or interference between EGF Like Domain Protein, Multiple 7 (EGFL7) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant EGF Like Domain Protein, Multiple 7 (EGFL7) and the recovery rates were calculated by comparing the measured value to the expected amount of EGF Like Domain Protein, Multiple 7 (EGFL7) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 91-99 95
EDTA plasma(n=5) 87-103 93
heparin plasma(n=5) 80-97 81

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level EGF Like Domain Protein, Multiple 7 (EGFL7) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level EGF Like Domain Protein, Multiple 7 (EGFL7) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of EGF Like Domain Protein, Multiple 7 (EGFL7) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-105% 80-92% 80-95% 93-101%
EDTA plasma(n=5) 90-101% 78-93% 78-97% 93-102%
heparin plasma(n=5) 91-99% 83-103% 85-94% 81-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab PMC5443778
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. pubmed:28539619
International Journal of Clinical and Experimental Pathology EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells ISSN:1936-2625
Cancer Drug Resist MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPL643Hu01 Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7) Positive Control; Immunogen; SDS-PAGE; WB.
PAL643Hu01 Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) WB; IHC; ICC; IP.
MAL643Hu21 Monoclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) WB; IHC; ICC; IP.
SEL643Hu ELISA Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) Enzyme-linked immunosorbent assay for Antigen Detection.
LML643Hu Multiplex Assay Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PGL643Hu01 Primer Pair for EGF Like Domain Protein, Multiple 7 (EGFL7) PCR